Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using response surface models to analyze drug combinations.

Nathaniel R Twarog1, Nancy E Martinez1, Jessica Gartrell2

  • 1Department of Chemical Biology and Therapeutics, St Jude Children's Research Hospital, Memphis, TN, USA.

Drug Discovery Today
|June 13, 2021
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decoding the shared genetic liability of lower respiratory tract infections via genomic structural equation modeling.

BMC pulmonary medicine·2026
Same author

Electronic structure-driven sodiophilicity enables stable anode-free sodium batteries.

Science advances·2026
Same author

HDAC1-mediated CDK1 decrotonylation inhibits colorectal cancer proliferation by regulating cell cycle and apoptosis.

Frontiers in oncology·2026
Same author

Factors influencing postoperative pain catastrophizing in patients with lower limb trauma and development of a nomogram prediction model.

BMC surgery·2026
Same author

Clinical characteristics and temporal trends of meropenem and piperacillin/tazobactam heteroresistance in Pseudomonas aeruginosa isolates.

Annals of clinical microbiology and antimicrobials·2026
Same author

Lipidomics reveals AMI-induced brown adipose tissue lipid remodeling linked to serum lipid changes in mice.

Analytical biochemistry·2026

Index-based drug combination evaluation methods are biased and unstable. Response surface models offer a more reliable approach for analyzing drug synergy and antagonism in development.

Area of Science:

  • Pharmacology
  • Biostatistics
  • Drug Development

Background:

  • Quantitative evaluation of drug combinations is vital for pharmaceutical research and development.
  • Current index-based methods for assessing drug combinations are prone to bias and instability.
  • These limitations can lead to inaccurate conclusions regarding drug synergy or antagonism.

Purpose of the Study:

  • To critically examine the inherent biases and instability of index-based methods in drug combination evaluation.
  • To introduce response surface models as a superior alternative for analyzing drug interactions.
  • To demonstrate the broad applicability of response surface models across diverse experimental data types.

Main Methods:

  • Analysis of bias patterns generated by traditional index-based drug combination evaluation techniques.
Keywords:
Combination therapyResponse surface modelsSynergy

Related Experiment Videos

  • Application of response surface models to various datasets, including therapeutic windows and discrete measures.
  • Adaptation of response surface models for complex scenarios like three-way drug combinations and atypical responses.

    • Main Results:

    • Demonstrated how index-based methods can produce misleading patterns, resulting in incorrect synergy/antagonism assessments.
    • Response surface models exhibit greater robustness against bias and instability.
    • Response surface models successfully analyzed diverse and complex drug combination data from recent literature.

    Conclusions:

    • Response surface models provide a more accurate and stable framework for quantitative drug combination evaluation.
    • The limitations of index-based methods necessitate the adoption of more reliable modeling techniques.
    • Response surface modeling is a versatile tool applicable to a wide spectrum of drug combination studies in development.